Vaughan David Investments LLC IL bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 252,873 shares of the financial services provider’s stock, valued at approximately $46,913,000. Vaughan David Investments LLC IL owned approximately 0.05% of Marsh & McLennan Companies as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Brighton Jones LLC raised its stake in shares of Marsh & McLennan Companies by 51.2% in the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock valued at $1,856,000 after purchasing an additional 2,960 shares during the period. Bison Wealth LLC grew its holdings in shares of Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after buying an additional 869 shares in the last quarter. Glenview Trust co raised its position in Marsh & McLennan Companies by 10.8% in the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after buying an additional 379 shares during the last quarter. Osterweis Capital Management Inc. lifted its stake in Marsh & McLennan Companies by 18,440.0% in the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock valued at $203,000 after acquiring an additional 922 shares in the last quarter. Finally, Diversify Advisory Services LLC acquired a new position in Marsh & McLennan Companies during the 2nd quarter worth approximately $1,307,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Insider Activity
In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Read Our Latest Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Trading Up 0.6%
Shares of MRSH stock opened at $168.20 on Friday. The firm has a market capitalization of $81.26 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 2.43 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $220.32. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion for the quarter. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, research analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Build On a Strong Earnings Season With These 3 ETFs
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
